D.R. AKBEROVA, E.S. BODRYAGINA, V.V. LYAPINA, S.F. ISHKINA

Kazan State Medical University, Kazan

 Contact details:

Akberova D.R. — PhD (Medicine), Assistant Lecturer of the Department of Hospital Therapy

Address: 49 Butlerov St., 420012 Kazan, Russian Federation, tel.: +7 (843) 237-32-61, e-mail: dilyara.akberova@kazangmu.ru

The liver is the second largest organ in the body; it participates in the homeostasis of carbohydrates, proteins, lipids, bile production, storage and filtration of blood. Liver dysfunction affects almost all body systems, manifesting itself in changes in the skin and mucous membranes color, the color of urine and feces changes, itching of the skin, and vascular manifestations. At the stage of damage like liver cirrhosis, portal hypertension and other complications may occur. Skin manifestations are a common and sometimes the most noticeable aspect of an objective examination. Due to their clarity, they attract both the patient’s and the doctor’s attention. The doctor’s task is to timely identify and link dermatological changes and clinical manifestations. Most skin manifestations are asymptomatic and do not require any specific therapy, but their early detection can help diagnose a liver disease, prevent or delay the development of complications and end-stage disease, reducing morbidity. The review discusses non-specific skin manifestations associated with liver diseases of various etiologies.

Key words: skin lesions, liver diseases, hepatitis, liver cirrhosis.

REFERENCES

1. Uspenskaya Yu.B. Chronic skin diseases through the prism of gastrointestinal tract pathology. Effektivnaya farmakoterapiya, 2016, vol. 30, pp. 34–46 (in Russ.).
2. Dubnyak N.S. et al. Skin symptoms in diseases of the gastrointestinal tract. Clinical lecture. Tikhookeanskiy meditsinskiy zhurnal, 2024, no. 2 (96), pp. 14–20 (in Russ.). DOI: 10.34215/1609-1175-2024-2-14-20
3. Akberova D.R., Bodryagina E.S., Mingatina L.I. Dermatological changes in some diseases of the gastrointestinal tract. Prakticheskaya meditsina, 2024, vol. 22, no. 4, pp. 10–16 (in Russ.).
4. Ivashkin V.T., Okhlobystin A.V., Shifrin O.S. Gastroenterologiya. Farmakoterapiya bez oshibok. Rukovodstvo dlya vrachey [Gastroenterology. Pharmacotherapy without errors. Guide for doctors]. E-noto, 2022. 416 p.
5. Zaslavskiy D.V. et al. Porazheniya kozhi pri boleznyakh vnutrennikh organov. Illyustrirovannoe rukovodstvo dlya vrachey [Skin lesions in diseases of internal organs. Illustrated guide for doctors]. Moscow: GEOTAR-Media, 2020. 352 p.
6. Mukhametova D.D. et al. Liver transplantation as a radical method of treating Wilson-Konovalov disease using a clinical case as an example. Prakticheskaya meditsina, 2024, vol. 22, no. 4, pp. 195-198 (in Russ.).
7. Trukhan D.I., Viktorova I.A., Bagisheva N.V. Skin changes in somatic diseases. Mezhdunarodnyy zhurnal prikladnykh i fundamental’nykh issledovaniy, 2016, no. 8-5, pp. 736–740 (in Russ.).
8. Patel A.D., Katz K., Gordon K.B. Cutaneous manifestations of chronic liver disease. Clin. Liver Dis, 2020, vol. 24 (3), pp. 351–360.
9. Fujino H. et al. Pruritus in patients with chronic liver disease and serum autotaxin levels in patients with primary biliary cholangitis. BMC gastroenterology, 2019, vol. 19, pp. 1–8. DOI: 10.1186/s12876-019-1092-z
10. De Vloo C., Nevens F. Cholestatic pruritus: an update. Acta Gastroenterol Belg, 2019, vol. 82 (1), pp. 75–82.
11. Kremer A.E., Elferink R.P.J.O., Beuers U. Pathophysiology and current management of pruritus in liver disease. Clin. Res. Hepatol. Gastroenterol, 2011, vol. 35 (2), pp. 89–97.
12. Hegade V.S. et al. A systematic approach to the management of cholestatic pruritus in primary biliary cirrhosis. Front. Gastroenterol, 2016, vol. 7 (3), pp. 158–166.
13. Nevens F. et al. A placebo-controlled trial of obeticholic acid in primary biliary cholangitis. New Engl. J. Med, 2016, vol. 375, no. 7, pp. 631–643.
14. Zak A. et al. Xanthomas: Clinical and pathophysiological relations. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech. Repub, 2014, vol. 158 (2), pp. 181–188. DOI: 10.5507/bp.2014.016
15. Dronova O.B. et al. Xanthomatosis and xanthomas of the stomach. Eksperimental’naya i klinicheskaya gastroenterologiya, 2021, vol. 189, no. 5, pp. 86–91 (in Russ.). DOI: 10.31146/1682-8658-ecg-189-5-86-91
16. Pankratov V.G. Xanthomatosis of the skin and mucous membranes as manifestations of dyslipidemia. Meditsinskie novosti, 2014, no. 6 (237), pp. 15–20 (in Russ.).
17. Zil’berberg N.V. et al. Xanthomatosis of the skin and mucous membranes as manifestations of dyslipidemia. Lechashchiy vrach, 2020, no. 8, pp. 44–47 (in Russ.).
18. Yakovlev A.B. Dermatological symptoms of liver cirrhosis: the significance of an interdisciplinary problem. RMZh, 2014, no. 20, p. 1471 (in Russ.).
19. El’kin V.D., Kobernik M.Yu. A rare clinical case of multiple eruptive xanthoma with severe hyperlipidemia and hyperglycemia. Vyatskiy meditsinskiy vestnik, 2024, no. 1, pp. 97–100 (in Russ.). DOI: 10.24412/2220-7880-2024-1-97-100
20. Bhandari A., Mahajan R. Skin shanges in sirrhosis. J. Clin. Exp. Hepatol, 2022, vol. 12 (4), rr. 1215–1224. DOI: 10.1016/j.jceh.2021.12.013
21. Vaishnav B. et al. Study of gonadal hormones in males with liver cirrhosis and its correlation with Child-Turcotte-Pugh and model for end-stage liver disease scores. Cureus, 2023, vol. 15 (1), e34035. DOI: 10.7759/cureus.34035
22. Kalra S., Bhattacharya S., Rawal P. Hepatocrinology. Med. Sci. (Basel), 2021, ovl. 9 (2), p. 39. DOI: 10.3390/medsci9020039
23. Liu Y. et al. Recognizing skin conditions in patients with cirrhosis: a narrative review. Ann. Med, 2022, vol. 54 (1), pp. 3017–3029. DOI: 10.1080/07853890.2022.2138961
24. Ivashkin V.T. et al. Clinical guidelines of the Russian Society for the Study of the Liver and the Russian Gastroenterological Association for the diagnosis and treatment of liver fibrosis and cirrhosis and their complications. Rossiyskiy zhurnal gastroenterologii, gepatologii, koloproktologii, 2021, vol. 31 (6), pp. 56–102 (in Russ.).
25. Oakley A.M., Patel B.C. Stretch Marks. StatPearls Publishing, 2023. PMID: 28613776